SU513628A3 - Способ получени 15 , 16 -метилен4-эстрен-17 -олов - Google Patents

Способ получени 15 , 16 -метилен4-эстрен-17 -олов

Info

Publication number
SU513628A3
SU513628A3 SU1891803A SU1891803A SU513628A3 SU 513628 A3 SU513628 A3 SU 513628A3 SU 1891803 A SU1891803 A SU 1891803A SU 1891803 A SU1891803 A SU 1891803A SU 513628 A3 SU513628 A3 SU 513628A3
Authority
SU
USSR - Soviet Union
Prior art keywords
methylene
methyl
natural
dimethyl
estren
Prior art date
Application number
SU1891803A
Other languages
English (en)
Russian (ru)
Inventor
Вихерт Рудольф
Штейнбек Херманн
Елгер Вальтер
Original Assignee
Шеринг Аг (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шеринг Аг (Фирма) filed Critical Шеринг Аг (Фирма)
Application granted granted Critical
Publication of SU513628A3 publication Critical patent/SU513628A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SU1891803A 1972-02-11 1973-02-09 Способ получени 15 , 16 -метилен4-эстрен-17 -олов SU513628A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
SU513628A3 true SU513628A3 (ru) 1976-05-05

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1891803A SU513628A3 (ru) 1972-02-11 1973-02-09 Способ получени 15 , 16 -метилен4-эстрен-17 -олов

Country Status (29)

Country Link
JP (1) JPS5829317B2 (US07498051-20090303-C00003.png)
KR (1) KR780000156B1 (US07498051-20090303-C00003.png)
AT (1) AT327413B (US07498051-20090303-C00003.png)
AU (1) AU467306B2 (US07498051-20090303-C00003.png)
BE (1) BE795241A (US07498051-20090303-C00003.png)
CA (1) CA997753A (US07498051-20090303-C00003.png)
CH (2) CH590883A5 (US07498051-20090303-C00003.png)
CS (1) CS193019B2 (US07498051-20090303-C00003.png)
DD (1) DD102379A5 (US07498051-20090303-C00003.png)
DE (1) DE2207421C3 (US07498051-20090303-C00003.png)
DK (1) DK131037B (US07498051-20090303-C00003.png)
EG (1) EG10914A (US07498051-20090303-C00003.png)
ES (1) ES410933A1 (US07498051-20090303-C00003.png)
FI (1) FI52225C (US07498051-20090303-C00003.png)
FR (1) FR2181719B1 (US07498051-20090303-C00003.png)
GB (1) GB1425636A (US07498051-20090303-C00003.png)
GR (1) GR63160B (US07498051-20090303-C00003.png)
HU (1) HU165253B (US07498051-20090303-C00003.png)
IE (1) IE37266B1 (US07498051-20090303-C00003.png)
IL (1) IL41506A (US07498051-20090303-C00003.png)
NL (1) NL177217C (US07498051-20090303-C00003.png)
NO (2) NO140304C (US07498051-20090303-C00003.png)
PH (1) PH9370A (US07498051-20090303-C00003.png)
PL (1) PL81084B1 (US07498051-20090303-C00003.png)
RO (1) RO73527A (US07498051-20090303-C00003.png)
SE (3) SE403781B (US07498051-20090303-C00003.png)
SU (1) SU513628A3 (US07498051-20090303-C00003.png)
YU (1) YU35035B (US07498051-20090303-C00003.png)
ZA (1) ZA73944B (US07498051-20090303-C00003.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
GR63160B (en) 1979-09-25
YU35035B (en) 1980-06-30
SE426834B (sv) 1983-02-14
DK131037C (US07498051-20090303-C00003.png) 1975-10-20
JPS5829317B2 (ja) 1983-06-22
NO143065B (no) 1980-09-01
FI52225B (US07498051-20090303-C00003.png) 1977-03-31
DE2207421A1 (de) 1973-08-16
DE2207421B2 (de) 1980-07-24
DD102379A5 (US07498051-20090303-C00003.png) 1973-12-12
SE7514513L (sv) 1975-12-22
YU24373A (en) 1979-12-31
NL7301974A (US07498051-20090303-C00003.png) 1973-08-14
NO140304B (no) 1979-04-30
FR2181719A1 (US07498051-20090303-C00003.png) 1973-12-07
IE37266B1 (en) 1977-06-08
NO782754L (no) 1973-08-14
NO143065C (no) 1980-12-10
ES410933A1 (es) 1976-03-01
CS193019B2 (en) 1979-09-17
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
AU467306B2 (en) 1975-11-27
FR2181719B1 (US07498051-20090303-C00003.png) 1975-11-21
IL41506A0 (en) 1973-04-30
BE795241A (fr) 1973-08-09
HU165253B (US07498051-20090303-C00003.png) 1974-07-27
ATA112473A (de) 1975-04-15
JPS4886856A (US07498051-20090303-C00003.png) 1973-11-15
AU5207673A (en) 1974-08-15
EG10914A (en) 1976-09-30
NL177217B (nl) 1985-03-18
CH590883A5 (US07498051-20090303-C00003.png) 1977-08-31
GB1425636A (en) 1976-02-18
AT327413B (de) 1976-01-26
IE37266L (en) 1973-08-11
PL81084B1 (US07498051-20090303-C00003.png) 1975-08-30
IL41506A (en) 1976-07-30
CA997753A (en) 1976-09-28
PH9370A (en) 1975-10-22
CH593995A5 (US07498051-20090303-C00003.png) 1977-12-30
DE2207421C3 (de) 1981-05-07
FI52225C (fi) 1977-07-11
NL177217C (nl) 1985-08-16
ZA73944B (en) 1973-11-28
KR780000156B1 (en) 1978-05-02
RO73527A (ro) 1982-02-01
SE7713896L (sv) 1977-12-07
DK131037B (da) 1975-05-20
SE409329B (sv) 1979-08-13

Similar Documents

Publication Publication Date Title
SU973025A3 (ru) Способ получени 17 @ -алкилстероидов
Wiersig et al. Stereospecific synthesis of the side chain of the steroidal plant sex hormone oogoniol
Wicha et al. Synthesis of 21-hydroxycholesterol and 25-hydroxycholesterol from 3β-hydroxyandrost-5-en-17-one. A method for the stereospecific construction of sterol side-chains
EP0050325B1 (de) Verfahren zur Herstellung von Zwischenprodukten in der Synthese von Vitamin D3-Metaboliten und neue Zwischenprodukte
SU513628A3 (ru) Способ получени 15 , 16 -метилен4-эстрен-17 -олов
Eadon et al. Mass spectrometry in structural and stereochemical problems. CCXI. Effect of structural variations on the electron impact-induced fragmentations of steroid hydrocarbons
FI72526C (fi) Nya 17-oxazolinsteroidderivat, deras framstaellningsfoerfarande och tillaempning vid framstaellning av kortikosteroider.
SU676170A3 (ru) Способ получени 7-оксиэстрадиолов
US3299108A (en) 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto
Marwah et al. Steroidal allylic fluorination using diethylaminosulfur trifluoride: A convenient method for the synthesis of 3β-acetoxy-7α-and 7β-fluoroandrost-5-en-17-one
WO2014037873A1 (en) Process for preparing 11 -methylene-18-methyl-estr-4-en-3, 17- dione, useful as intermediate compound for the synthesis of molecules having a pharmacological activity
US2782212A (en) 14-methyl pregnenes and method
Miyano Synthesis of aldosterone
US2677695A (en) Process for preparing 17alpha-hydroxy 20-keto steroids
Pinto et al. Bismuth (III) salt-catalyzed Westphalen and “backbone” rearrangements of 5β, 6β-epoxysteroids: Synthesis and structural elucidation of new olefinic 19-nor and 18, 19-dinorsteroids
US2773885A (en) Steroids of the ergosta series
EP0053845B1 (en) 17-beta-ethynylsteroids and process for preparing same
WO2004094450A1 (en) Process for preparing guggulsterones and guggulsterol
US3058999A (en) Method for the preparation of 16-keto steroids
US3435055A (en) 7-methylestr-2-en-17-one and derivatives thereof
US2740797A (en) Steroids
Scheer et al. Rearrangement of 20-substituted bisnorallocholanes and derivatives
Palmer et al. The preparation of 3α-and 3β, 17β-dihydroxy-17α-ethynyl-estr-5 (10)-ene 1
US3450697A (en) Process for the preparation of 5(10),7-dehydro-steroids
Ghosh et al. Pentacyclic steroids. 5. Total synthesis of 4, 6. beta.-ethano-3-methoxy-8. alpha.-estra-1, 3, 5 (10)-trien-17. beta.-ol and 4, 6. alpha.-ethano-3-methoxyestra-1, 3, 5 (10), 8, 14-pentaen-17-one